175 related articles for article (PubMed ID: 10754381)
1. Four cases of bleeding diathesis in children due to congenital plasminogen activator inhibitor-1 deficiency.
Minowa H; Takahashi Y; Tanaka T; Naganuma K; Ida S; Maki I; Yoshioka A
Haemostasis; 1999; 29(5):286-91. PubMed ID: 10754381
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activator inhibitor type 1 deficiency.
Mehta R; Shapiro AD
Haemophilia; 2008 Nov; 14(6):1255-60. PubMed ID: 19141166
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen activator inhibitor with very long half-life (VLHL PAI-1) can reduce bleeding in PAI-1-deficient patients.
Jankun J; Skrzypczak-Jankun E
Cardiovasc Hematol Disord Drug Targets; 2013 Aug; 13(2):144-50. PubMed ID: 23988002
[TBL] [Abstract][Full Text] [Related]
4. Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activity.
Agren A; Wiman B; Schulman S
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):657-60. PubMed ID: 17890953
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study.
Wiman B; Andersson T; Hallqvist J; Reuterwall C; Ahlbom A; deFaire U
Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):2019-23. PubMed ID: 10938026
[TBL] [Abstract][Full Text] [Related]
6. Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor.
Schleef RR; Higgins DL; Pillemer E; Levitt LJ
J Clin Invest; 1989 May; 83(5):1747-52. PubMed ID: 2496147
[TBL] [Abstract][Full Text] [Related]
7. Laboratory evaluation of patients with undiagnosed bleeding disorders.
Alves GS; Orsi FA; Santiago-Bassora FD; Quaino SK; Montalvão SA; Paula EV; Annichino-Bizzacchi JM
Blood Coagul Fibrinolysis; 2016 Jul; 27(5):500-5. PubMed ID: 26825625
[TBL] [Abstract][Full Text] [Related]
8. Hereditary partial deficiency of plasminogen activator inhibitor-1 associated with a lifelong bleeding tendency.
Takahashi Y; Tanaka T; Minowa H; Ookubo Y; Sugimoto M; Nakajima M; Miyauchi Y; Yoshioka A
Int J Hematol; 1996 Jul; 64(1):61-8. PubMed ID: 8757969
[TBL] [Abstract][Full Text] [Related]
9. Systemic or topical application of plasminogen activator inhibitor with extended half-life (VLHL PAI-1) reduces bleeding time and total blood loss.
Jankun J; Keck R; Selman SH; Skrzypczak-Jankun E
Int J Mol Med; 2010 Oct; 26(4):501-4. PubMed ID: 20818488
[TBL] [Abstract][Full Text] [Related]
10. [Anesthetic management of a patient with congenital plasminogen activator inhibitor-1 deficiency].
Kajihara A; Kurehara H; Kitaguchi K; Furuya H; Morimoto Y; Kirita T; Fukuda K; Takahashi Y
Masui; 2003 Jan; 52(1):73-5. PubMed ID: 12632627
[TBL] [Abstract][Full Text] [Related]
11. [Hemorrhagic syndrome and isolated alpha 2-antiplasmin deficiency. Apropos of a case].
Guermazi S; Khelif A; Conrad J; Ennabli S; Dellagi K
Pathol Biol (Paris); 1997 Jun; 45(6):483-6. PubMed ID: 9309264
[TBL] [Abstract][Full Text] [Related]
12. Haemostatic management of intraoral bleeding in patients with congenital deficiency of alpha2-plasmin inhibitor or plasminogen activator inhibitor-1.
Morimoto Y; Yoshioka A; Imai Y; Takahashi Y; Minowa H; Kirita T
Haemophilia; 2004 Sep; 10(5):669-74. PubMed ID: 15357795
[TBL] [Abstract][Full Text] [Related]
13. Successful arthroscopic treatment of pigmented villonodular synovitis of the knee in a patient with congenital deficiency of plasminogen activator inhibitor-1 and recurrent haemarthrosis.
Matsui H; Takahashi Y; Matsunaga T; Tanaka-Horie T; Minowa H; Sugimoto M; Tsukino R; Mii Y; Giddings J; Yoshioka A
Haemostasis; 2001; 31(2):106-12. PubMed ID: 11684866
[TBL] [Abstract][Full Text] [Related]
14. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium.
Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
Agents Actions Suppl; 1992; 38 ( Pt 2)():320-9. PubMed ID: 1462839
[TBL] [Abstract][Full Text] [Related]
15. Excessive fibrinolysis in suspected amyloidosis: demonstration of plasmin-alpha 2-plasmin inhibitor complex and von Willebrand factor fragment in plasma.
Takahashi H; Koike T; Yoshida N; Kitahara O; Hanano M; Shibata A; Aoki N
Am J Hematol; 1986 Oct; 23(2):153-66. PubMed ID: 2944378
[TBL] [Abstract][Full Text] [Related]
16. Deficiency of plasma plasminogen activator inhibitor 1 results in hyperfibrinolytic bleeding.
Lee MH; Vosburgh E; Anderson K; McDonagh J
Blood; 1993 May; 81(9):2357-62. PubMed ID: 8481516
[TBL] [Abstract][Full Text] [Related]
17. A familial hemorrhagic diathesis in a Dutch family: an inherited deficiency of alpha 2-antiplasmin.
Kluft C; Vellenga E; Brommer EJ; Wijngaards G
Blood; 1982 Jun; 59(6):1169-80. PubMed ID: 6177359
[TBL] [Abstract][Full Text] [Related]
18. Imbalance of plasminogen activator inhibitor type-1 (PAI-1) and tissue plasminogen activator (t-PA) activity in patients with Noonan syndrome.
Mehta P; Parker RI
J Pediatr Hematol Oncol; 2010 Oct; 32(7):532-6. PubMed ID: 20686427
[TBL] [Abstract][Full Text] [Related]
19. Human plasminogen activator inhibitor-1 (PAI-1) deficiency: characterization of a large kindred with a null mutation in the PAI-1 gene.
Fay WP; Parker AC; Condrey LR; Shapiro AD
Blood; 1997 Jul; 90(1):204-8. PubMed ID: 9207454
[TBL] [Abstract][Full Text] [Related]
20. [Report of a case of congenital plasminogen activator inhibitor-1 deficiency].
Zhang ZY; Wang ZY; Fu JX; Dong NZ; Zhang W; Bai X; Ruan CG
Zhonghua Xue Ye Xue Za Zhi; 2004 Mar; 25(3):129-31. PubMed ID: 15182577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
